STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

POAI PREDICTIVE ONCOLOGY INCORPORATED StockScouter® Report

5

StockScouter® Score

PREDICTIVE ONCOLOGY INCORPORATED, a micro cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with slightly higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
  • The enterprise value-to-sales ratio is approximately in line with that of comparably-sized companies in the StockScouter universe. Neutral

 

Concerns

  • Moving average analysis for POAI suggests weak price movement over the medium term. Negative
  • Shares are being sold by financial institutions. Slightly negative for a small company like POAI

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, growth stocks will be neutral, and healthcare stocks will be neutral.

Expected Risk/Return

Progress: 80% done.
Progress: 40% done.
Low
High

Core Model Grades

C
C
C
C

Previous Ratings

3
2
2